Literature DB >> 25797887

The interdialytic weight gain: a simple marker of left ventricular hypertrophy in children on chronic haemodialysis.

Michael Fischbach1, Ariane Zaloszyc, Rukshana Shroff.   

Abstract

Despite multiple advances in haemodialysis (HD) technology over the years, the morbidity and mortality of HD patients remain unacceptably high. Cardiovascular disease is the most common cause of death, and left ventricular hypertrophy (LVH), seen in two-thirds of children on dialysis, is a significant contributor. The importance of volume control is increasingly recognized by nephrologists and now considered to be as important as urea kinetics, both in the day-to-day management and the long-term outcome of dialysis patients. The results published by Paglialonga et al. ( 10.1007/s00467-014-3005-2 ) in this issue of Pediatric Nephrology clearly demonstrate that there is a significant correlation between interdialytic weight gain (IDWG) and LVH in oligoanuric children on chronic HD and that children with an IDWG of >4 % are at high risk of LVH. One common practice to achieve euvolaemia is to prescribe very high ultrafiltration rates. However, both volume overload and aggressive fluid removal can induce circulatory stress and multi-organ injury. In adults, ultrafiltration rates of >1.24 % body weight per hour, even if well tolerated, are associated with a significant increase in mortality. Nephrologists should be aware of the risk of a high ultrafiltration rate, especially if tolerance is obtained by a positive dialysate-to-plasma sodium gradient. Haemodiafiltration, which allows for higher ultrafiltration rates with greater intradialytic haemodynamic stability, or more frequent and longer dialysis sessions allow for safe and effective fluid removal.

Entities:  

Mesh:

Year:  2015        PMID: 25797887     DOI: 10.1007/s00467-015-3086-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

1.  Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats.

Authors:  Jens Titze; Friedrich C Luft; Katharina Bauer; Peter Dietsch; Rainer Lang; Roland Veelken; Hubertus Wagner; Kai-Uwe Eckardt; Karl F Hilgers
Journal:  Hypertension       Date:  2006-04-24       Impact factor: 10.190

Review 2.  Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.

Authors:  Rajiv Agarwal; Matthew R Weir
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

4.  The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care.

Authors:  Jennifer E Flythe; Steven M Brunelli
Journal:  Semin Dial       Date:  2011-04-11       Impact factor: 3.455

Review 5.  Hemodiafiltration: the addition of convective flow to hemodialysis.

Authors:  Michel Fischbach; Helen Fothergill; Arianne Zaloszyc; Laure Seuge
Journal:  Pediatr Nephrol       Date:  2011-02-06       Impact factor: 3.714

6.  Reduction of left ventricular hypertrophy in children undergoing hemodialysis.

Authors:  Tim Ulinski; Julie Genty; Christine Viau; Isabelle Tillous-Borde; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

7.  Bioimpedance analysis and cardiovascular status in pediatric patients on chronic hemodialysis.

Authors:  Fabio Paglialonga; Gianluigi Ardissino; Maria A Galli; Rosalia V Scarfia; Sara Testa; Alberto Edefonti
Journal:  Hemodial Int       Date:  2012-10       Impact factor: 1.812

8.  Importance of the curve shape for interpretation of blood volume monitor changes during haemodiafiltration.

Authors:  Céline Dheu; Joelle Terzic; Soraya Menouer; Michel Fischbach
Journal:  Pediatr Nephrol       Date:  2009-03-07       Impact factor: 3.714

Review 9.  Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients.

Authors:  Sergio F F Santos; Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 8.237

10.  Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments.

Authors:  Daljit K Hothi; Lesley Rees; Jan Marek; James Burton; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

View more
  12 in total

1.  Bedside sonographic assessments for predicting predialysis fluid overload in children with end-stage kidney disease.

Authors:  Ahmet Yontem; Cagla Cagli; Dincer Yildizdas; Ozden Ozgur Horoz; Faruk Ekinci; Bahriye Atmis; Aysun Karabay Bayazit
Journal:  Eur J Pediatr       Date:  2021-04-30       Impact factor: 3.183

2.  Artificial intelligence outperforms experienced nephrologists to assess dry weight in pediatric patients on chronic hemodialysis.

Authors:  Olivier Niel; Paul Bastard; Charlotte Boussard; Julien Hogan; Thérésa Kwon; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

3.  Interdialytic weight gain and vasculopathy in children on hemodialysis: a single center study.

Authors:  Vasiliki Karava; Cherine Benzouid; Theresa Kwon; Marie-Alice Macher; Georges Deschênes; Julien Hogan
Journal:  Pediatr Nephrol       Date:  2018-09-03       Impact factor: 3.714

4.  Improved blood pressure and left ventricular remodelling in children on chronic intermittent haemodialysis: a longitudinal study.

Authors:  Nabil Melhem; Alex Savis; Arran Wheatley; Helen Copeman; Kay Willmott; Christopher J D Reid; John Simpson; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2019-05-16       Impact factor: 3.714

5.  Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.

Authors:  Benjamin L Laskin; Guixia Huang; Eileen King; Denis F Geary; Christoph Licht; Joshua P Metlay; Susan L Furth; Tom Kimball; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2017-04-08       Impact factor: 3.714

6.  Hemodiafiltration maintains a sustained improvement in blood pressure compared to conventional hemodialysis in children-the HDF, heart and height (3H) study.

Authors:  Francesca De Zan; Colette Smith; Ali Duzova; Aysun Bayazit; Constantinos J Stefanidis; Varvara Askiti; Karolis Azukaitis; Nur Canpolat; Ayse Agbas; Ali Anarat; Bilal Aoun; Sevcan A Bakkaloglu; Dagmara Borzych-Dużałka; Ipek Kaplan Bulut; Sandra Habbig; Saoussen Krid; Christoph Licht; Mieczyslaw Litwin; Lukasz Obrycki; Fabio Paglialonga; Bruno Ranchin; Charlotte Samaille; Mohan Shenoy; Manish D Sinha; Brankica Spasojevic; Alev Yilmaz; Michel Fischbach; Claus Peter Schmitt; Franz Schaefer; Enrico Vidal; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2021-02-24       Impact factor: 3.714

7.  Nutritional status and volume control in adolescents on chronic hemodialysis.

Authors:  Fabio Paglialonga; Silvia Consolo; Marta Brambilla; Olga Caporale; Alejandro Cruz Gual; Maria Rosa Grassi; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2021-05-14       Impact factor: 3.714

8.  Relationship between Interdialytic Weight Gain and Blood Pressure in Pediatric Patients on Chronic Hemodialysis.

Authors:  Olivera Marsenic; Michael Anderson; Kevin G Couloures
Journal:  Biomed Res Int       Date:  2016-10-30       Impact factor: 3.411

9.  Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD-a large observational study with follow-up to young adult age.

Authors:  Verena Gotta; Olivera Marsenic; Andrew Atkinson; Marc Pfister
Journal:  Pediatr Nephrol       Date:  2021-03-02       Impact factor: 3.714

10.  Finding covert fluid: methods for detecting volume overload in children on dialysis.

Authors:  Marco Allinovi; Moin A Saleem; Owen Burgess; Catherine Armstrong; Wesley Hayes
Journal:  Pediatr Nephrol       Date:  2016-06-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.